About RemedyBio
RemedyBio is a company based in Dublin (Ireland) founded in 2017.. RemedyBio has raised $9.43 million across 4 funding rounds from investors including Enterprise Ireland, European Union and Dublin City University. RemedyBio offers products and services including Therapeutic Discovery Platform and Immune System Mapping Tool. RemedyBio operates in a competitive market with competitors including Annexon, Syndax, Abingdon Health, Clovis Oncology and Spear Bio, among others.
- Headquarter Dublin, Ireland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.43 M (USD)
in 4 rounds
-
Latest Funding Round
$22.91 K (USD), Grant
Jun 01, 2022
-
Investors
Enterprise Ireland
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RemedyBio
RemedyBio offers a comprehensive portfolio of products and services, including Therapeutic Discovery Platform and Immune System Mapping Tool. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for mapping cell functions to discover new immune therapies.
Tool that analyzes patient biology for therapeutic development.
Funding Insights of RemedyBio
RemedyBio has successfully raised a total of $9.43M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $22.91 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $22,914
-
First Round
First Round
(09 Jun 2020)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Grant - RemedyBio | Valuation |
investors |
|
| Jul, 2021 | Amount | Series A - RemedyBio | Valuation |
investors |
|
| Sep, 2020 | Amount | Grant - RemedyBio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in RemedyBio
RemedyBio has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Enterprise Ireland, European Union and Dublin City University. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Support is provided to Irish manufacturing and service sector businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by RemedyBio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RemedyBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Remedybio Comparisons
Competitors of RemedyBio
RemedyBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Annexon, Syndax, Abingdon Health, Clovis Oncology and Spear Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Targeted therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of immunoassays for diagnostic purposes
|
|
| domain | founded_year | HQ Location |
Develops innovative immunotherapy drugs for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers
|
|
| domain | founded_year | HQ Location |
Developer of cancer therapeutics for the treatment of blood cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Remedybio
Frequently Asked Questions about RemedyBio
When was RemedyBio founded?
RemedyBio was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is RemedyBio located?
RemedyBio is headquartered in Dublin, Ireland.
Is RemedyBio a funded company?
RemedyBio is a funded company, having raised a total of $9.43M across 4 funding rounds to date. The company's 1st funding round was a Grant of $2.98M, raised on Jun 09, 2020.
What does RemedyBio do?
RemedyBio was founded in 2017 in Dublin, Ireland, within the biotechnology sector. Personalized, cell-based, and autologous therapies targeting tumors are developed and offered. Nanoscale biotechnology is employed for diagnostic purposes in immunoncology, autoimmune diseases, and infectious conditions. Individual cell functions are analyzed across 10 million to 1 billion living cells to support therapeutic design and evaluation.
Who are the top competitors of RemedyBio?
RemedyBio's top competitors include Syndax, Annexon and Abingdon Health.
What products or services does RemedyBio offer?
RemedyBio offers Therapeutic Discovery Platform and Immune System Mapping Tool.
Who are RemedyBio's investors?
RemedyBio has 5 investors. Key investors include Enterprise Ireland, European Union, Dublin City University, Science Foundation Ireland, and EIC Fund.